Innovation1 Biotech Inc.
IVBT
OTC PK
| 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | 17.00K | 17.00K | 17.00K |
| Gross Profit | -- | -- | -17.00K | -17.00K | -17.00K |
| SG&A Expenses | 793.40K | 1.25M | 1.62M | 2.11M | 2.75M |
| Depreciation & Amortization | 1.20K | 1.20K | 763.70K | 1.66M | 2.55M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 794.40K | 1.27M | 2.62M | 4.01M | 5.53M |
| Operating Income | -794.40K | -1.27M | -2.62M | -4.01M | -5.53M |
| Income Before Tax | -5.61M | -5.99M | -38.78M | -40.09M | -41.27M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.61 | -5.99 | -38.78 | -40.09 | -41.27 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.61M | -5.99M | -38.78M | -40.09M | -41.27M |
| EBIT | -794.40K | -1.27M | -2.62M | -4.01M | -5.53M |
| EBITDA | -793.40K | -1.27M | -1.89M | -2.43M | -3.54M |
| EPS Basic | -0.68 | -0.70 | -2.93 | -2.99 | -2.68 |
| Normalized Basic EPS | -0.07 | -0.08 | -0.10 | -0.14 | -0.19 |
| EPS Diluted | -0.68 | -0.70 | -2.93 | -2.99 | -2.68 |
| Normalized Diluted EPS | -0.07 | -0.08 | -0.10 | -0.14 | -0.19 |
| Average Basic Shares Outstanding | 81.94M | 80.84M | 75.59M | 75.29M | 75.29M |
| Average Diluted Shares Outstanding | 81.94M | 80.84M | 75.59M | 75.29M | 75.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |